Specific inhibition of oncogenic RAS using cell-permeable RAS-binding domains.

Cell Chemical Biology
Teiko Komori NomuraRyo Honda

Abstract

Oncogenic RAS proteins, common oncogenic drivers in many human cancers, have been refractory to conventional small-molecule and macromolecule inhibitors due to their intracellular localization and the lack of druggable pockets. Here, we present a feasible strategy for designing RAS inhibitors that involves intracellular delivery of RAS-binding domain (RBD), a nanomolar-affinity specific ligand of RAS. Screening of 51 different combinations of RBD and cell-permeable peptides has identified Pen-cRaf-v1 as a cell-permeable pan-RAS inhibitor capable of targeting both G12C and non-G12C RAS mutants. Pen-cRaf-v1 crosses the cell membrane via endocytosis, competitively inhibits RAS-effector interaction, and thereby exerts anticancer activity against several KRAS-mutant cancer cell lines. Moreover, Pen-cRaf-v1 exhibits excellent activity comparable with a leading pan-RAS inhibitor (BI-2852), as well as high target specificity in transcriptome analysis and alanine mutation analysis. These findings demonstrate that specific inhibition of oncogenic RAS, and possibly treatment of RAS-mutant cancer, is feasible by intracellular delivery of RBD.

References

Apr 28, 1995·The Journal of Biological Chemistry·T R BrtvaC J Der
Jul 5, 2003·Molecular Therapy : the Journal of the American Society of Gene Therapy·Mathias LundbergMagnus Johansson
Jun 16, 2004·Proceedings of the National Academy of Sciences of the United States of America·C KielC Herrmann
Apr 14, 2005·Journal of Molecular Biology·Sabine WohlgemuthChristian Herrmann
Sep 3, 2005·Analytical Biochemistry·Külliki SaarUlo Langel
Jan 19, 2006·The Journal of Biological Chemistry·Aki FujiokaMichiyuki Matsuda
Mar 6, 2009·Nature·Kohsuke InomataMasahiro Shirakawa
May 1, 2013·Proceedings of the National Academy of Sciences of the United States of America·Fumi ShimaTohru Kataoka
Jan 21, 2014·Nature Chemical Biology·Matthew J Smith, Mitsuhiko Ikura
Jan 7, 2016·Proceedings of the National Academy of Sciences of the United States of America·James E DixonKevin M Shakesheff
Mar 18, 2016·Journal of Cell Science·G Aaron HobbsKent L Rossman
Apr 23, 2016·Cell·Sai Krishna Athuluri-DivakarE Premkumar Reddy
Feb 18, 2017·Trends in Pharmacological Sciences·Giulia GuidottiDaniela Rossi
Feb 25, 2017·Cell·Matthew E WelschBrent R Stockwell
Apr 15, 2019·Biochemical and Biophysical Research Communications·Ryota SugawaraRyo Honda
Jul 25, 2019·Proceedings of the National Academy of Sciences of the United States of America·Dirk KesslerDarryl B McConnell
Sep 13, 2019·Science Translational Medicine·Ann LinJason M Sheltzer
Nov 5, 2019·Biochimica Et Biophysica Acta. Molecular Cell Research·Imran KhanJohn P O'Bryan

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.